COIN vs STRO
Coinbase Global Inc (COIN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported COIN revenue for 2025-12-31 was $7.18B. Net income was $1.26B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the COIN and STRO stock pages for the full models.
Not investment advice.